The Conceptual Framework for the Therapeutic Approach used in Phase 3 Trials of MDMA-AT for PTSD
Kelley C O'Donnell, Michael Alpert, Lauren Okano et al. preprint
Results from multiple recent studies support the use of 3,4-methylenedioxymethamphetamine (MDMA) in conjunction with psychotherapy (i.e., MDMA-Assisted Therapy) in the treatment of post-traumatic stress disorder (PTSD). In two Phase 3 trials, MDMA-Assisted Therapy comprised a short-term, intensive psychotherapy that included three sessions directly facilitated by MDMA (referred to as...
DOI: 10.31219/osf.io/gey78 (opens in new tab)
Psychedelic-assisted therapy
PTSD Treatment
Trauma therapy
Trauma care
+21